BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15214437)

  • 21. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
    Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
    J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of short hydrophobic and basic-rich peptides.
    Chen PW; Shyu CL; Mao FC
    Am J Vet Res; 2003 Sep; 64(9):1088-92. PubMed ID: 13677384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling of anti-HSV activity of lactoferricin analogues using amino acid descriptors.
    Jenssen H; Gutteberg TJ; Lejon T
    J Pept Sci; 2005 Feb; 11(2):97-103. PubMed ID: 15635641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence requirements and an optimization strategy for short antimicrobial peptides.
    Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
    Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
    Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
    J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of bovine lactoferrin inter-lobe region to iron binding stability and antimicrobial activity against Staphylococcus aureus.
    Bai X; Teng D; Tian Z; Zhu Y; Yang Y; Wang J
    Biometals; 2010 Jun; 23(3):431-9. PubMed ID: 20145976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity, structure and CMC relationships of alkanediyl alpha,omega-bis(dimethylammonium bromide) surfactants.
    Laatiris A; El Achouri M; Infante MR; Bensouda Y
    Microbiol Res; 2008; 163(6):645-50. PubMed ID: 17207986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.
    Haukland HH; Vorland LH
    J Antimicrob Chemother; 2001 Oct; 48(4):569-71. PubMed ID: 11581240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformation and activity of delta-lysin and its analogs.
    Dhople VM; Nagaraj R
    Peptides; 2005 Feb; 26(2):217-25. PubMed ID: 15629533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and QSAR modeling of 2-acetyl-2-ethoxycarbonyl-1-[4(4'-arylazo)-phenyl]-N,N-dimethylaminophenyl aziridines as potential antibacterial agents.
    Sharma P; Kumar A; Upadhyay S; Sahu V; Singh J
    Eur J Med Chem; 2009 Jan; 44(1):251-9. PubMed ID: 18396359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin.
    Staubitz P; Peschel A; Nieuwenhuizen WF; Otto M; Götz F; Jung G; Jack RW
    J Pept Sci; 2001 Oct; 7(10):552-64. PubMed ID: 11695650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lewis acid-promoted transformation of 2-alkoxypyridines into 2-aminopyridines and their antibacterial activity. Part 2: Remarkably facile C-N bond formation.
    Abdel-Aziz AA; El-Subbagh HI; Kunieda T
    Bioorg Med Chem; 2005 Aug; 13(16):4929-35. PubMed ID: 15993091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, antibacterial activity and QSAR studies of 1,2-disubstituted-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines.
    Tiwari RK; Singh D; Singh J; Chhillar AK; Chandra R; Verma AK
    Eur J Med Chem; 2006 Jan; 41(1):40-9. PubMed ID: 16356593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel lysine-peptoid hybrids with antibacterial properties.
    Ryge TS; Hansen PR
    J Pept Sci; 2005 Nov; 11(11):727-34. PubMed ID: 16161020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-Aminotetralones: novel inhibitors of MurA and MurZ.
    Dunsmore CJ; Miller K; Blake KL; Patching SG; Henderson PJ; Garnett JA; Stubbings WJ; Phillips SE; Palestrant DJ; Angeles Jde L; Leeds JA; Chopra I; Fishwick CW
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1730-4. PubMed ID: 18261901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin.
    van der Kraan MI; Groenink J; Nazmi K; Veerman EC; Bolscher JG; Nieuw Amerongen AV
    Peptides; 2004 Feb; 25(2):177-83. PubMed ID: 15062998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel and efficient one step synthesis of 2-amino-5-cyano-6-hydroxy-4-aryl pyrimidines and their anti-bacterial activity.
    Deshmukh MB; Salunkhe SM; Patil DR; Anbhule PV
    Eur J Med Chem; 2009 Jun; 44(6):2651-4. PubMed ID: 19036478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D-QSAR, synthesis, and antimicrobial activity of 1-alkylpyridinium compounds as potential agents to improve food safety.
    Rodríguez-Morales S; Compadre RL; Castillo R; Breen PJ; Compadre CM
    Eur J Med Chem; 2005 Sep; 40(9):840-9. PubMed ID: 16194718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel antibacterial peptides by chemoinformatics and machine learning.
    Fjell CD; Jenssen H; Hilpert K; Cheung WA; Panté N; Hancock RE; Cherkasov A
    J Med Chem; 2009 Apr; 52(7):2006-15. PubMed ID: 19296598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro reconstitution of antimicrobial pathogen activity by expressed recombinant bovine lactoferrin N-terminal peptide in Escherichia coli.
    Luo H; Chen S; Ren F; Guo H; Lin S; Xu W
    J Dairy Res; 2007 May; 74(2):233-8. PubMed ID: 17466115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.